SurgePays, Inc. (NASDAQ:SURG - Get Free Report)'s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.76 and traded as high as $2.90. SurgePays shares last traded at $2.83, with a volume of 97,817 shares changing hands.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the company. Wall Street Zen raised SurgePays from a "sell" rating to a "hold" rating in a report on Saturday, August 30th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of SurgePays in a report on Wednesday. Finally, Ascendiant Capital Markets lifted their target price on SurgePays from $9.00 to $9.50 and gave the company a "buy" rating in a report on Friday, October 3rd. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $9.50.
Get Our Latest Research Report on SURG
SurgePays Stock Up 0.4%
The company has a debt-to-equity ratio of 101.87, a current ratio of 1.11 and a quick ratio of 0.84. The company has a market cap of $57.82 million, a PE ratio of -1.14 and a beta of 0.43. The company has a fifty day moving average price of $2.74 and a 200 day moving average price of $2.76.
SurgePays (NASDAQ:SURG - Get Free Report) last issued its quarterly earnings data on Wednesday, August 13th. The medical equipment provider reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.05). SurgePays had a negative return on equity of 333.87% and a negative net margin of 133.85%.The business had revenue of $11.52 million for the quarter, compared to analysts' expectations of $16.14 million. SurgePays has set its FY 2025 guidance at EPS. As a group, analysts anticipate that SurgePays, Inc. will post -1.66 EPS for the current year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of SURG. Jones Financial Companies Lllp grew its holdings in shares of SurgePays by 34,091.3% during the first quarter. Jones Financial Companies Lllp now owns 51,287 shares of the medical equipment provider's stock worth $106,000 after purchasing an additional 51,137 shares in the last quarter. XTX Topco Ltd bought a new stake in SurgePays in the 2nd quarter worth approximately $125,000. Ethos Financial Group LLC bought a new stake in SurgePays in the 1st quarter worth approximately $57,000. Cetera Investment Advisers lifted its position in SurgePays by 61.0% in the 2nd quarter. Cetera Investment Advisers now owns 45,400 shares of the medical equipment provider's stock worth $141,000 after buying an additional 17,200 shares during the last quarter. Finally, Baader Bank Aktiengesellschaft bought a new stake in SurgePays in the 1st quarter worth approximately $35,000. Hedge funds and other institutional investors own 6.94% of the company's stock.
About SurgePays
(
Get Free Report)
SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SurgePays, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.
While SurgePays currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.